Insufficient scRNA-seq data for expression of ANAPC2 at single-cell level.
Insufficient scRNA-seq data for expression of ANAPC2 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 2550.48 | 1445 / 1445 | 100% | 28.11 | 183 / 183 |
liver | 100% | 1894.26 | 226 / 226 | 100% | 23.40 | 406 / 406 |
pancreas | 100% | 2226.06 | 328 / 328 | 100% | 25.65 | 178 / 178 |
uterus | 100% | 3171.52 | 170 / 170 | 100% | 29.53 | 459 / 459 |
prostate | 100% | 4050.01 | 245 / 245 | 100% | 40.23 | 501 / 502 |
lung | 100% | 2747.96 | 578 / 578 | 100% | 22.60 | 1151 / 1155 |
stomach | 100% | 2467.97 | 359 / 359 | 100% | 23.34 | 285 / 286 |
intestine | 100% | 2840.52 | 966 / 966 | 100% | 24.64 | 525 / 527 |
adrenal gland | 100% | 2967.38 | 258 / 258 | 100% | 24.57 | 229 / 230 |
kidney | 100% | 2386.43 | 89 / 89 | 100% | 23.12 | 897 / 901 |
ovary | 100% | 3185.01 | 180 / 180 | 100% | 23.91 | 428 / 430 |
thymus | 100% | 3329.52 | 653 / 653 | 100% | 27.05 | 602 / 605 |
brain | 99% | 2355.42 | 2628 / 2642 | 100% | 41.51 | 705 / 705 |
breast | 100% | 3245.62 | 459 / 459 | 99% | 29.29 | 1111 / 1118 |
skin | 100% | 3135.17 | 1809 / 1809 | 99% | 26.48 | 469 / 472 |
bladder | 100% | 2740.24 | 21 / 21 | 99% | 25.74 | 499 / 504 |
adipose | 100% | 2649.08 | 1204 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 30.36 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 42.26 | 29 / 29 |
spleen | 100% | 4015.20 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 28.24 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 27.59 | 1 / 1 |
blood vessel | 100% | 2212.76 | 1334 / 1335 | 0% | 0 | 0 / 0 |
muscle | 100% | 1752.39 | 801 / 803 | 0% | 0 | 0 / 0 |
heart | 99% | 1638.21 | 850 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 97% | 1834.86 | 901 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0070979 | Biological process | protein K11-linked ubiquitination |
GO_0051445 | Biological process | regulation of meiotic cell cycle |
GO_0031915 | Biological process | positive regulation of synaptic plasticity |
GO_0045773 | Biological process | positive regulation of axon extension |
GO_0010629 | Biological process | negative regulation of gene expression |
GO_0007091 | Biological process | metaphase/anaphase transition of mitotic cell cycle |
GO_0051301 | Biological process | cell division |
GO_0031145 | Biological process | anaphase-promoting complex-dependent catabolic process |
GO_0070936 | Biological process | protein K48-linked ubiquitination |
GO_0050775 | Biological process | positive regulation of dendrite morphogenesis |
GO_0030154 | Biological process | cell differentiation |
GO_0007346 | Biological process | regulation of mitotic cell cycle |
GO_0090129 | Biological process | positive regulation of synapse maturation |
GO_0007399 | Biological process | nervous system development |
GO_0005680 | Cellular component | anaphase-promoting complex |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005829 | Cellular component | cytosol |
GO_0031625 | Molecular function | ubiquitin protein ligase binding |
GO_0005515 | Molecular function | protein binding |
Gene name | ANAPC2 |
Protein name | Anaphase-promoting complex subunit 2 (APC2) (Cyclosome subunit 2) |
Synonyms | APC2 KIAA1406 |
Description | FUNCTION: Together with the RING-H2 protein ANAPC11, constitutes the catalytic component of the anaphase promoting complex/cyclosome (APC/C), a cell cycle-regulated E3 ubiquitin ligase that controls progression through mitosis and the G1 phase of the cell cycle. The APC/C complex acts by mediating ubiquitination and subsequent degradation of target proteins: it mainly mediates the formation of 'Lys-11'-linked polyubiquitin chains and, to a lower extent, the formation of 'Lys-48'- and 'Lys-63'-linked polyubiquitin chains. The CDC20-APC/C complex positively regulates the formation of synaptic vesicle clustering at active zone to the presynaptic membrane in postmitotic neurons. CDC20-APC/C-induced degradation of NEUROD2 drives presynaptic differentiation. . |
Accessions | ENST00000323927.3 [Q9UJX6-1] Q9UJX6 |